Cambridge Investment Research Advisors, Inc. Takeda Pharmaceutical CO LTD Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$13.89 - $15.04 $4,903 - $5,309	353 Added 3.34%	10,930 $152,000
Q4 2023 Feb 09, 2024	SELL	$13.36 - $15.43 $78,236 - $90,358	-5,856 Reduced 35.64%	10,577 $151,000
Q3 2023 Oct 24, 2023	BUY	$15.03 - $16.32 $13,271 - $14,410	883 Added 5.68%	16,433 $254,000
Q2 2023 Jul 13, 2023	SELL	$15.57 - $17.11 $5,215 - $5,731	-335 Reduced 2.11%	15,550 $244,000
Q1 2023 May 11, 2023	BUY	$15.28 - $16.48 $3,560 - $3,839	233 Added 1.49%	15,885 $262,000
Q4 2022 Feb 08, 2023	BUY	$12.42 - $15.62 $7,911 - $9,949	637 Added 4.24%	15,652 $244,000
Q3 2022 Oct 17, 2022	SELL	$12.8 - $28.65 $7,296 - $16,330	-570 Reduced 3.66%	15,015 $194,000
Q2 2022 Jul 13, 2022	BUY	$13.12 - $15.03 $21,110 - $24,183	1,609 Added 11.51%	15,585 $218,000
Q1 2022 May 12, 2022	SELL	$13.54 - $15.35 $45,995 - $52,143	-3,397 Reduced 19.55%	13,976 $200,000
Q4 2021 Feb 03, 2022	SELL	$13.17 - $16.4 $24,917 - $31,028	-1,892 Reduced 9.82%	17,373 $236,000
Q3 2021 Nov 02, 2021	SELL	$16.3 - $17.26 $29,323 - $31,050	-1,799 Reduced 8.54%	19,265 $315,000
Q2 2021 Aug 10, 2021	BUY	$16.55 - $18.64 $8,275 - $9,320	500 Added 2.43%	21,064 $354,000
Q1 2021 May 07, 2021	BUY	$16.71 - $19.9 $138,977 - $165,508	8,317 Added 67.91%	20,564 $375,000
Q4 2020 Feb 04, 2021	SELL	$15.39 - $18.97 $11,250 - $13,867	-731 Reduced 5.63%	12,247 $222,000
Q3 2020 Oct 29, 2020	BUY	$17.1 - $19.19 $27,513 - $30,876	1,609 Added 14.15%	12,978 $231,000
Q2 2020 Jul 27, 2020	BUY	$14.59 - $19.5 $165,873 - $221,695	11,369 New	11,369 $203,000
Q2 2019 Aug 15, 2019	SELL	$16.58 - $20.49 $171,636 - $212,112	-10,352 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$16.7 - $21.52 $172,878 - $222,775	10,352 New	10,352 $0

Others Institutions Holding TAK

# of Institutions

320

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$182 Million
0.04% of portfolio
Mondrian Investment Partners LTD London, X0

7.74M
Shares

$107 Million
1.74% of portfolio
Morgan Stanley New York, NY

4.99M
Shares

$69.1 Million
0.01% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.35M
Shares

$60.2 Million
0.03% of portfolio
Goldman Sachs Group Inc New York, NY

3.72M
Shares

$51.5 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account